Please complete the CAPTCHA to continue
@pfizer.com
✓
1 phone found area 406
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mingming Han, Ph.D. is listed as Principal Scientist Processs Development at Pfizer, based in Sanford, North Carolina, United States. AeroLeads shows a work email signal at pfizer.com, phone signal with area code 406, and a matched LinkedIn profile for Mingming Han, Ph.D..
Mingming Han, Ph.D. previously worked as Principal Scientist at Pfizer Pharmaceuticals and Senior Development Scientist at Sanofi Pasteur. Mingming Han, Ph.D. holds Phd, Chemistry from University Of North Dakota.
This section adds company-level context without repeating Mingming Han, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Mingming Han, Ph.D.. Compare company email patterns before reaching out.
A chemist specialized in conjugate vaccine development, from early stage development, pilot plant, to commercial scale DS production in supporing of new products launching with global pharmaceutical companies. A main investigator for development of several major bacterial polysaccharide–protein vaccine products including: Second Generation Meningococcal Conjugate (Menactra Next Generation, 4-valent); Next Generation Pneumococcal Conjugate (Prevnar Next Generation, 20-valent); Group B Streptococcal Conjugate Vaccines (6 valent). Experiences in GMP, RegTox, Clinical Material, Technology Transfer, CTM, Process Validation, Risk Assessment, Process Development and Optimization using science and risk base Quality by Design (QbD) / DOE statistical approach.
Listed skills include Biopharmaceuticals, Vaccine Research And Development, Biotechnology, Technology Transfer, and 19 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New York, New York, Us
Globe Manufacturing Science and Technology•Primary responsibilities include improvement, scale-up, troubleshooting and technology transfer of manufacturing processes for late-stage and marketed vaccines. •Current work deal with supporting lunching of Pfizer's Next Generation 20-valent pneumococcal conjugate vaccine etc. •New technique development for conjugate vaccine
New York, New York, Us
Vaccine research and development•Served as a main investigator on the highest priority new conjugation vaccine project (New generation of multi-valent Pneumococcal Conjugate Vaccine) for R&D.•Works including new initial chemistry screening (direct coupling and linker chemistry), development of purification and analytical methods, DOE of new serotypes.•Development of processes for the DEMO lots and Phase I/II clinic trail material of multiple candidate glycoconjugate vaccines.•Tech Transfer, activities in manufactured GMP lots in the pilot plant and commercial manufacturing facility.•Development of multi-valent Group B Streptococcus - protein conjugate vaccine including early stage process development, alternative chemistry screening, preparation of Reg-Tox material, and Tech Transfer.
Paris, France, Fr
Vaccine research and development•Development work related to 2nd generation of multi-valent Meningococcal Conjugate Vaccine•Process optimization and scale-up activities for the Tech Transfer of 2nd generation of meningococcal conjugate vaccine new to the Industrializations group.- Optimized TFF, chromatography and conjugation processes with the goals of minimizing consumables and processing times and maximizing yields•Activity in manufactured 2 Phase II GMP lots in the pilot plant facility.•Phase III process development of purification and analysis of protein based C. difficile vaccine •Post-licensure yield improvement development studies for the currently licensed conjugate vaccine (Menactra) for the Industrializations group. •Worked closely with vendors on the development of new pre-packed chromatography media and new membrane chromatography devices.•Development works related to new Pneumococcal Conjugate Vaccine for R&D.
Carlsbad, Ca, Us
Antisense drug discovery and development•Scale-up/process development of standard & modified nucleosides and their phosphoramidites in supporting company’s antisense drug discovery research•Design & Synthesis of modified nucleosides for more stable monomers•Managing the quality control of incoming materials
Vaccine research and development•Development of Group B Streptococcus (GBS) vaccines
Quick answers generated from the profile data available on this page.
Mingming Han, Ph.D. works for Pfizer.
Mingming Han, Ph.D. is listed as Principal Scientist Processs Development at Pfizer.
AeroLeads has found 1 work email signal at @pfizer.com for Mingming Han, Ph.D. at Pfizer.
AeroLeads has found 1 phone signal(s) with area code 406 for Mingming Han, Ph.D. at Pfizer.
Mingming Han, Ph.D. is based in Sanford, North Carolina, United States while working with Pfizer.
Mingming Han, Ph.D. has worked for Pfizer, Pfizer Pharmaceuticals, Sanofi Pasteur, Ionis Pharmaceuticals, Inc., and Channing Laboratory Of Harvard Medical School.
You can use AeroLeads to view verified contact signals for Mingming Han, Ph.D. at Pfizer, including work email, phone, and LinkedIn data when available.
Mingming Han, Ph.D. holds Phd, Chemistry from University Of North Dakota.
Mingming Han, Ph.D. is listed with skills including Biopharmaceuticals, Vaccine Research And Development, Biotechnology, Technology Transfer, Life Sciences, Chromatography, Validation, and Protein Chemistry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts